홈 > 시장보고서 > 의료기기 > 바이오장비

시장보고서

상품코드

1289777

세계의 단백질 엔지니어링 시장(2023-2030년)

Global Protein Engineering Market - 2023-2030

발행일: 2023년 06월 | 리서치사:

DataM Intelligence | 페이지 정보: 영문 195 Pages | 배송안내 : 1-2일 (영업일 기준)

■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

시장 개요

세계의 단백질 엔지니어링 시장은 2022년 22억 4,720만 달러, 2030년에는 67억 2,130만 달러에 달할 것으로 예상되며, 유리한 성장이 전망됩니다. 세계의 단백질 엔지니어링 시장은 예측 기간(2023-2030년) 동안 15.2%의 CAGR을 보일 것으로 예상됩니다.

단백질 엔지니어링은 기존 특성을 개선하거나 기능을 추가하기 위해 단백질을 수정하거나 개발하는 과정입니다. 또한 안정성, 특이성, 활성 및 기타 원하는 특성을 향상시키기 위해 단백질의 구조, 서열 및 특성을 수정하는 것도 포함됩니다.

세계의 단백질 엔지니어링 시장은 기술 개발, 단백질 기반 의약품에 대한 수요 증가, 여러 분야에서 단백질의 응용 분야가 확대됨에 따라 빠르게 발전하고 있습니다.

시장 역학

단백질 기반 의약품에 대한 수요 증가가 세계 단백질 엔지니어링 시장을 견인할 것으로 예상됩니다.

세계의 단백질 엔지니어링 시장의 주요 촉진요인 중 하나는 당뇨병의 빈도가 증가함에 따라 단백질 기반 치료제에 대한 수요가 증가하고 있다는 점입니다. 차지하고 있습니다.

미국에서는 당뇨병 유병률이 증가함에 따라 인슐린뿐만 아니라 단백질 엔지니어링을 기반으로 한 인공 인슐린에 대한 수요도 증가할 것으로 예상됩니다. 따라서 위의 요인으로 인해 세계 단백질 엔지니어링 시장은 예측 기간 중 확대될 것으로 보입니다.

단백질 엔지니어링 세계 시장은 높은 장비 비용에 따른 제약이 있을 수 있습니다.

단백질 엔지니어링은 질량 분석기, 크로마토그래피 시스템, 하이스루풋 스크리닝 플랫폼과 같은 고급 툴와 장비를 사용해야 합니다. 이러한 장비는 구입, 유지 및 개선에 많은 비용이 소요될 수 있습니다.

특히 경영 자원이 한정된 중소기업과 연구기관의 경우, 높은 장비 비용은 단백질 엔지니어링 기술에 대한 투자 장벽으로 작용하고 있습니다. 이러한 이유로 세계 단백질 엔지니어링 시장은 예측 기간 중 큰 제약 요인에 직면하게 될 것입니다.

COVID-19의 영향 분석

COVID-19의 유행은 치료제와 진단약에 대한 수요 증가로 인해 연구개발 활동을 촉진하여 단백질 엔지니어링 사업에 큰 영향을 미쳤습니다. 단백질 엔지니어링 접근법은 백신 개발, 항바이러스제 설계, 진단 테스트 개발 등에 활용되고 있습니다.

공동 연구, 자금 조달, 바이러스 단백질과 면역 반응에 대한 연구 전환은 단백질 엔지니어링의 발전을 촉진하고 있습니다. 그러나 공급망 중단으로 인해 어려움이 발생했습니다. 전반적으로 팬데믹은 세계 건강 문제를 해결하는 데 있으며, 단백질 엔지니어링의 관련성을 강조하고 이 분야의 기술 혁신에 박차를 가했습니다.

러시아·우크라이나 분쟁 분석

러시아와 우크라이나의 분쟁이 세계 단백질 엔지니어링 산업에 미치는 직접적인 영향은 제한적이었습니다. 그러나 공급망 혼란, 경제 불안정, 연구 협력 긴장, 인력 이동, 규제 변경/무역 장벽 등 간접적인 영향이 있을 수 있습니다.

이러한 요인들은 자원의 가용성, 투자 결정, 연구 자금, 과학 개발 및 단백질 엔지니어링의 세계 인재 풀에 영향을 미칠 수 있습니다. 그러나 지정학적 갈등은 업계에 영향을 미치는 몇 가지 변수 중 하나일 뿐이며, 과학의 발전과 시장 수요가 더 큰 영향을 미칩니다는 점을 강조하는 것이 중요합니다.

Market Overview

The Global Protein Engineering Market reached US$ 2,247.2 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 6,721.3 million by 2030. The global protein engineering market is expected to exhibit a CAGR of 15.2% during the forecast period (2023-2030).

Protein engineering is the process of altering or developing proteins in order to improve existing characteristics or add additional functionality. It also entails tinkering with protein structure, sequence, and characteristics in order to increase their stability, specificity, activity, and other desirable traits.

The global protein engineering market is developing rapidly as a result of technological developments, rising demand for protein-based pharmaceuticals, and the expanding uses of proteins in numerous sectors.

Market Dynamics

The Growing Demand for Protein Based Drug is Expected to Drive the Global Protein Engineering Market

One of the major drivers of the worldwide protein engineering market is the increasing need for protein-based therapeutics as the frequency of diabetes rises. According to the CDC's National Diabetes Statistics Report for 2022, 37.3 million people in the United States have diabetes, accounting for 11.3% of the total population.

Because of the rising prevalence of diabetes in the United States, demand for insulin, as well as protein-engineered artificial insulin, is predicted to rise. Therefore, owing to the above factor the global protein engineering market will boost over the forecast period.

The Global Protein Engineering Market May Face Constraints due to the High Cost of Instruments

Protein engineering requires the utilization of advanced tools and equipment such as mass spectrometers, chromatography systems, and high-throughput screening platforms. Such equipment can be costly to buy, maintain, and improve.

The high cost of instruments is a barrier to investment in protein engineering technologies, particularly for small and medium-sized firms (SMEs) or research institutes with restricted resources. Owing to this reason the global protein engineering market will face a major restraint over the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a substantial influence on the protein engineering business, with increasing demand for treatments and diagnostics driving research and development activities. Protein engineering approaches have been used in vaccine development, antiviral medication design, and diagnostic test development.

Collaboration, financing, and a shift in research focus to viral proteins and immunological responses have propelled advances in protein engineering. However, supply chain interruptions have presented difficulties. Overall, the pandemic has highlighted the relevance of protein engineering in tackling global health issues and has fueled innovation in the area.

Russia-Ukraine Conflict Analysis

The war between Russia and Ukraine has had a limited direct influence on the global protein engineering industry. However, indirect repercussions such as supply chain disruptions, economic instability, strained research collaborations, talent migration, and regulatory changes/trade barriers are possible.

These factors may have an impact on resource availability, investment decisions, research funding, scientific development, and the global talent pool in protein engineering. However, it is vital to highlight that geopolitical conflicts are only one of several variables influencing the industry, with scientific developments and market demand having a larger impact.

Segment Analysis

The global protein engineering market is segmented based on product type, protein type, technology, end user, and region.

The Biopharmaceutical Companies Segment is Expected to Dominate the Global Protein Engineering Market

The biopharmaceutical companies segment is projected to dominate the protein engineering market and will account for the highest market share of 52.5%, due to the high proportion utilization of in silico drug research models for treating diabetes, cancer, and neurological illnesses. For example, top pharmaceutical firms such as Novo Nordisk, AstraZeneca, and Eli Lilly have prioritized revenue growth through the discovery of novel treatments.

Furthermore, the biopharmaceutical companies segment is expanding due to increased financing and investment assistance from both public and private healthcare organizations. For instance, in March 2023, Sanofi's acquisition of Provention Bio brought a new, first-in-class medication for type 1 diabetes to its general medicines core asset portfolio. Therefore, the adoption of in-silico techniques and an increase in funding will drive the segment growth of the global protein engineering market size over the forecast period.

Geographical Analysis

North America Region Holds the Largest Market Share of the Global Protein Engineering Market

The global protein engineering market is dominated by North America and holds 2/5th market share due to better healthcare spending, technological advancements, presence of major market players leading to drug development, collaboration, and advanced healthcare infrastructure.

For instance, in January 2023. Proteinea, a biotech startup based in the U.S. and Egypt, is pioneering computational protein engineering technology, as they are releasing Ankh, the most sophisticated and high-performing open-source protein language model in the world. Proteinea created Ankh in collaboration with Google and the Technical University of Munich, using funding from Google's cloud innovators program.

Competitive Landscape

The major global players in the market include: GE Healthcare, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Bruker Corporation, Genscript Biotech Corporation, Codexis, Waters Corporation, New England Biolabs, and Merck KGaA.

Why Purchase the Report?

To visualize global protein engineering market segmentation based on product type, protein type, technology, end user, and region and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of global protein engineering market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global protein engineering market report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Market Snippet by Product Type
3.2. Market Snippet by Protein Type
3.3. Market Snippet by Technology
3.4. Market Snippet by End User
3.5. Market Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The growing demand for protein-based drug
- 4.1.2. Restraints
  - 4.1.2.1. High cost of instruments
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer's Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Consumables
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Instruments
7.4. Software & Services

8. By Protein Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Protein Type
- 8.1.2. Market Attractiveness Index, By Protein Type
8.2. Insulin
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Erythropoietin
8.4. Vaccines
8.5. Interferons
8.6. Coagulation Factors
8.7. Colony-Stimulating Factors
8.8. Growth Hormones
8.9. Monoclonal Antibodies

9. By Technology

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.1.2. Market Attractiveness Index, By Technology
9.2. Irrational Protein Design
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Rational Protein Design

10. By End User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.1.2. Market Attractiveness Index, By End User
10.2. Biopharmaceutical Companies*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Contract Research Organizations
10.4. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Protein Type
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. The U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Protein Type
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. The UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Protein Type
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Protein Type
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Protein Type
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. GE Healthcare*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Thermo Fisher Scientific, Inc.
13.3. Agilent Technologies, Inc.
13.4. Bio-Rad Laboratories, Inc.
13.5. Bruker Corporation
13.6. Genscript Biotech Corporation
13.7. Codexis, Inc.
13.8. Waters Corporation
13.9. New England Biolabs, Inc.
13.10. Merck KGaA

LIST NOT EXHAUSTIVE

14. Appendix

14.1. About Us and Services
14.2. Contact Us

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF & Excel (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,350

￦ 6,173,000

PDF & Excel (Multiple User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,850

￦ 6,882,000

PDF & Excel (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,850

￦ 11,139,000

※ 부가세 별도